Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Change in Moderate-Vigorous Physical Activity [MVPA] |
ActiGraph accelerometers are validated as measures of physical activity and have been used in numerous studies of physical activity in patients with medical illness. In this trial, participants will wear the accelerometer for one week at baseline, 6 weeks, and 12 weeks. We will report change from baseline to 6 weeks and 12 weeks in the average number of minutes of MVPA performed per day. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Proportion of text message sessions completed |
To assess the feasibility of the MASTERY intervention the automated platform will record rates of the proportion of text message sessions in which participants respond and set a physical activity goal. |
Weekly over 12 weeks. |
|
Secondary |
Mean utility ratings of positive psychology text messages |
Participants will rate the utility of the positive psychology text message sessions over the past six weeks on a scale of 0 (unhelpful) to 10 (very helpful). |
6 weeks; 12 weeks |
|
Secondary |
Mean utility ratings of physical activity text messages |
Participants will rate the utility of the physical activity text message sessions over the past six weeks on a scale of 0 (unhelpful) to 10 (very helpful). |
6 weeks; 12 weeks |
|
Secondary |
Mean utility ratings of stress reduction text messages |
Participants will rate the utility of the stress reduction text message sessions over the past six weeks on a scale of 0 (unhelpful) to 10 (very helpful). |
6 weeks; 12 weeks |
|
Secondary |
Mean utility ratings of phone check-ins |
Participants will rate the utility of the phone sessions over the past six weeks on a scale of 0 (unhelpful) to 10 (very helpful). |
6 weeks; 12 weeks |
|
Secondary |
Change in overall physical activity |
ActiGraph accelerometers are validated as measures of physical activity and have been used in numerous studies of physical activity in patients with medical illness. In this trial, participants will wear the accelerometer for one week at baseline, 6 weeks, and 12 weeks. We will report change from baseline to 6 weeks and 12 weeks in the average number of steps per day. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in sedentary leisure time |
ActiGraph accelerometers are validated as measures of physical activity and have been used in numerous studies of physical activity in patients with medical illness. In this trial, participants will wear the accelerometer for one week at baseline, 6 weeks, and 12 weeks. We will report change from baseline to 6 weeks and 12 weeks in the average number of minutes of sedentary leisure time per day. Participants will indicate which hours represent leisure time during workdays and off days/weekends to allow us to ascertain this outcome. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in self-reported physical activity |
The International Physical Activity Questionnaire (IPAQ) is a well-validated 7-day physical activity recall assessment for physical activity. Activity will be measured by the number of MET-minutes of moderate or greater activity per week, and change will be assessed by subtracting the baseline score from the 6- and 12-week scores. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in positive affect (positive affect items of the Positive and Negative Affect Schedule [PANAS]) |
The positive affect items on the Positive and Negative Affect Schedule (PANAS), a well-validated scale used in other intervention trials and in patients with medical illnesses, will be used to measure positive affect (Range: 10-50). Change will be calculated by subtracting the score at baseline from the score at 6 and 12 weeks. Higher scores indicate higher levels of positive affect. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in optimism (Life Orientation Test - Revised [LOT-R]) |
The Life Orientation Test-Revised is a well-validated 6-item instrument used to measure dispositional optimism (Range: 0-24). Change will be calculated by subtracting the score at baseline from the score at 6 and 12 weeks. Higher scores indicate higher levels of optimism. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in life satisfaction (Satisfaction with Life Scale [SWLS]) |
The Satisfaction with Life Scale is a 5-item scale designed to measure global cognitive judgments of one's life satisfaction (Range: 5-35). Change will be calculated by subtracting the score at baseline from the score at 6 and 12 weeks. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in depressive symptoms (Hospital Anxiety and Depression Scale depression subscale [HADS-D]) |
The Hospital Anxiety and Depression Scale depression subscale (HADS-D) will be used to measure depression. This is a well-validated scale with few somatic symptom items that can confound mood/anxiety assessment in medically-ill patients (Range: 0-21). Change will be calculated by subtracting the score at baseline from the score at 6 and 12 weeks. Higher scores indicate higher levels of depression. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in anxiety (Hospital Anxiety and Depression Scale anxiety subscale [HADS-A]) |
The Hospital Anxiety and Depression Scale (HADS)-anxiety subscale will be used to measure depression. This is a well-validated scale with few somatic symptom items that can confound mood/anxiety assessment in medically-ill patients (Range: 0-21). Change will be calculated by subtracting the score at baseline from the score at 6 and 12 weeks. Higher scores indicate higher levels of anxiety. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in exercise self-efficacy (Self-efficacy for Exercise Scale [SES]) |
The Self-efficacy for Exercise Scale will be used to measure exercise self-efficacy. This is a 9-item scale used to assess an individual's beliefs in their ability to continue exercising on a three time per week basis at moderate intensities for 20+ minutes per session in the future. (Range: 0-90). Change will be calculated by subtracting the score at baseline from the score at 6 and 12 weeks. Higher scores indicate higher levels of self-efficacy. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in social support (Norbeck Social Support Questionnaire) |
The Norbeck Social Support Questionnaire will be used to assess an individual's perceived emotional and tangible support. Likert scale ratings for each person in the individual's social network will be made and the average across the social network will be calculated (Range:0-4). Change will be calculated by subtracting the score at baseline from the score at 6 and 12 weeks. Higher scores indicate higher levels of perceived social support. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in perceived constraints (perceived constraints subscale of the MIDUS Sense of Control measure) |
The 8-item subscale of the MIDUS Sense of Control measure will be used to measure internal locus of control - perceived constraints (Range: 8-56). Change will be calculated by subtracting the score at baseline from the score at 6 and 12 weeks. Higher scores indicate higher levels of perceived constraints. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in personal mastery (personal mastery subscale of the MIDUS Sense of Control measure) |
The 4-item subscale of the MIDUS Sense of Control measure will be used to measure internal locus of control - perceived constraints (Range: 4-28). Change will be calculated by subtracting the score at baseline from the score at 6 and 12 weeks. Higher scores indicate higher levels of perceived constraints. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in function (General Health Questionnaire-12 [GHQ-12]) |
The General Health Questionnaire-12 consists of 12 items and assesses function (Range: 0-36). Change will be calculated by subtracting the score at baseline from the score at 6 and 12 weeks. Higher scores indicate worse functional status. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in mental health related quality of life (Medical Outcomes Study Short Form-12 mental component score [SF-12 MCS]) |
Mental health related quality of life will be assessed via the mental component score of the Medical Outcomes Study SF-12 (Range: 0-100). Change will be calculated by subtracting the score at baseline from the score at 6 and 12 weeks. Higher scores indicate better health-related quality of life. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in physical health related quality of life (Medical Outcomes Study Short Form-12 physical component score [SF-12 PCS]) |
Physical health related quality of life will be assessed via the physical component score of the Medical Outcomes Study SF-12 (Range: 0-100). Change will be calculated by subtracting the score at baseline from the score at 6 and 12 weeks. Higher scores indicate better health-related quality of life. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in body weight |
Body weight (in kilograms) will be measured by nurses. Change will be calculated by subtracting the weight at baseline from the weight at 6 and 12 weeks. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in body mass index (in kilograms per square meter) |
Height and weight will be measured by nurses at baseline, 6, and 12 weeks. Change will be calculated by subtracting the baseline value from the value at 6 and 12 weeks. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in waist circumference (in centimeters) |
Waist circumference will be measured by nurses at baseline, 6, and 12 weeks. Change will be calculated by subtracting the baseline value from the value at 6 and 12 weeks. |
Baseline, 6 weeks, 12 weeks |
|
Secondary |
Change in blood pressure (millimeters of mercury) |
Blood pressure will be measured by nurses at baseline, 6, and 12 weeks. Change will be calculated by subtracting the baseline value from the value at 6 and 12 weeks. |
Baseline, 6 weeks, 12 weeks |
|